Skip to Search
Skip to Navigation
Skip to Content

University of Connecticut Health Center Pediatric Research

Inflammatory Bowel Disease (IBD) Laboratory

Contact the Laboratory

Francisco Sylvester
Email: fsylvester@uchc.edu

Anthony Vella
Email: vella@uchc.edu

In Collaboration

University of Connecticut Health Center         Connecticut Children's Medical Center

Publications

  1. Francolla KA, Altman A, Sylvester FA. Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab. J Pediatr Gastroenterol Nutr. 2008;47(2):193-5.
  2. Viswanathan A, Sylvester FA. Chronic pediatric inflammatory diseases: effects on bone. Rev Endocr Metab Disord. 2008;9(2):107-22.
  3. Sylvester FA, Wyzga N, Hyams JS, Davis PM, Lerer T, Vance K, Hawker G, Griffiths AM. Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:42-50.
  4. Sylvester FA. Does bone crack under the effects of IBD in children? Editorial. J Pediatr Gastroenterol Nutr accepted for publication, 2006.
  5. NASPGHAN Nutrition Report Committee: Michail S, Sylvester F, Fuchs G, Issenman R. Clinical Efficacy of Probiotics: Review of the Evidence With Focus on Children. J Pediatr Gastroenterol Nutr 2006;43:550-557.
  6. Athos Bousvaros, MD, MPH, Francisco Sylvester, MD, et al. Challenges in Pediatric Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2006;12:885-913.
  7. Sylvester FA. Bone and digestive disorders: In Pediatric Gastrointestinal Disease, pathophysiology, diagnosis, management, 3rd edition, 2006. Edited by Robert Wyllie, Jeffrey S. Hyams. Saunders.
  8. Sylvester FA. Protein-losing enteropathy: In Pediatric Gastrointestinal Disease, pathophysiology, diagnosis, management, 3rd edition, 2006. Edited by Robert Wyllie, Jeffrey S. Hyams. Saunders.
  9. Sylvester FA, Davis PM, Wyzga N, Hyams JS, Lerer T. Are activated T cells regulators of bone metabolism in children with Crohn disease? J Pediatr. 2006;148(4):461-466.
  10. Sylvester FA: Skeletal health in IBD: Children are not small adults! Inflamm Bowel Dis 2005 Nov;11(11):1020-3.
  11. Wyzga N, Varghese S, Wikel S, Canalis E, Sylvester FA. Effects of activated T cells on osteoclastogenesis depend on how they are activated. Bone. 2004;35(3):614-20.
  12. Sylvester FA. Cracking the risk of fractures in Crohn disease. Selected Summary. J Pediatr Gastroenterol Nutr 2004;38(1):113-4.
  13. Sylvester FA. Peptic Ulcer Disease (Chapter 316) In: Nelson Textbook of Pediatrics, 17th Edition, 2003. Edited by Richard Behrman, Robert Kliegman, Hal B. Jenson. Saunders.
  14. Sylvester FA. Other diseases of the esophagus. In: Pediatric Gastrointestinal Disease: pathophysiology, diagnosis, management, 2nd edition, 2003. Edited by Robert Wyllie, Jeffrey S. Hyams. Saunders.
  15. Varghese S, Wyzga N, Griffiths AM, Sylvester FA. Effects of serum from children with newly diagnosed Crohn disease on primary cultures of rat osteoblasts. J Pediatr Gastroenterol Nutr. 2002;35(5):641-8.
  16. Sylvester FA, Wyzga N, Hyams JS, Gronowicz GA. Effect of Crohn's disease on bone metabolism in vitro: a role for interleukin-6. J Bone Miner Res. 2002 Apr;17(4):695-702.
  17. Sylvester FA, Hyams JS. Appropriate use of corticosteroids in inflammatory bowel disease. In Bayless T, Hanauer S. Advanced therapy of inflammatory bowel disease. B.C. Decker, Hamilton, Ontario, 2001, p. 363-66.
  18. Sylvester FA. Bone abnormalities in gastrointestinal and hepatic disease. Rev Endocr Metab Disord. 2001 Jan;2(1):75-80.
  19. Sylvester FA. An update on bone abnormalities in gastrointestinal and liver disease. The Endocrinologist 2001;11(2):77-80.
  20. Hyams JS, Davis P, Sylvester FA, Zeiter DK, Justinich CJ, Lerer T. Dyspepsia in children and adolescents: a prospective study. J Pediatr Gastroenterol Nutr. 2000 Apr;30(4):413-8.
  21. Sajjan US, Sylvester FA, Forstner JF. Cable-piliated Burkholderia cepacia binds to cytokeratin 13 of epithelial cells. Infect Immun. 2000 Apr;68(4):1787-95.
  22. Sylvester FA. Bone abnormalities in gastrointestinal and hepatic disease. Curr Opin Pediatr. 1999 Oct;11(5):402-7.
  23. Sylvester FA, Shuckett B, Cutz E, Durie PR, Marcon M. Management of fibrosing pancreatitis in childhood presenting with obstructive jaundice. Gut 1998; 43:715-20.
  24. Sylvester FA, Gold B, Lastovica A, Sherman P, Forstner JF: Adherence to lipids and intestinal mucin by a recently recognized human pathogen Campylobacter upsaliensis. Infection & Immunity 1996;64(10):4060-4066.
  25. Sylvester F. A rare for of chronic granulomatous disease presenting as inflammatory bowel disease. Canadian Journal of Gastroenterology 1996;10(4):221-224.
  26. Sylvester FA, Sajjan US, Forstner JF: Burkholderia (Basonym Pseudomonas) cepacia binding to lipid receptors. Infection & Immunity 1996; 64(4):1420-1425.
  27. Forstner JF, Oliver MG, Sylvester F. Production, structure and biologic relevance of gastrointestinal mucins. In: Infections of the Gastrointestinal Tract, Editor: J.I. Ravdin. Raven Press, New York, 1995. Pages: 71-88.
  28. Sylvester FA, Griffiths AM: Endothelins and the color of mice: unraveling the etiopathogenesis of Hirschprung disease (Selected Summary). Journal of Pediatric Gastroenterology & Nutrition, 1995;21:478-479.
  29. Griffiths A, Koletzko S, Sylvester F, Marcon M, Sherman P: Slow-release 5-aminosalicylic acid therapy in children with small intestinal Crohn's disease. Journal of Pediatric Gastroenterology and Nutrition 1993; 17: 186-192.
  30. Sylvester FA, Sajjan US, Forstner, JF. Pseudomonas cepacia binds to globotriosylceramide (Gb3). Pediatric Research 1993; 33 Pt 2: 185A.Sylvester F, Shah B, Finberg L: Growth hormone studies in familial hypophosphatemia. Pediatric Research 1991; 29 Pt 2: 502A.